Australia markets closed

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.91+0.16 (+1.64%)
At close: 04:00PM EDT
9.88 -0.03 (-0.30%)
After hours: 06:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
423,489
399,356
329,233
305,514
260,886
-
Cost of revenue
43,951
37,326
38,599
34,466
31,044
-
Gross profit
379,538
362,030
290,634
271,048
229,842
-
Operating expenses
Research development
139,211
152,381
276,677
272,049
308,443
-
Selling general and administrative
289,342
275,270
213,041
192,710
156,407
-
Total operating expenses
437,323
435,524
495,060
470,968
473,696
-
Operating income or loss
-57,785
-73,494
-204,426
-199,920
-243,854
-
Interest expense
50,741
50,149
37,119
32,471
22,425
-
Total other income/expenses net
-38,358
-33,536
-3,518
-9,672
-11,201
-
Income before tax
-140,465
-150,101
-242,039
-241,554
-274,254
-
Income tax expense
6,606
1,483
-5,471
8,906
2,598
-
Income from continuing operations
-147,071
-151,584
-236,568
-250,460
-276,852
-
Net income
-147,071
-151,584
-236,568
-250,460
-276,852
-
Net income available to common shareholders
-147,071
-151,584
-236,568
-250,460
-276,852
-
Basic EPS
-0.59
-
-0.82
-0.92
-1.07
-1.48
Diluted EPS
-0.59
-
-0.82
-0.92
-1.07
-1.48
Basic average shares
292,412
-
289,057
271,422
258,867
240,421
Diluted average shares
292,412
-
289,057
271,422
258,867
240,421